Overview

Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children

Status:
Completed
Trial end date:
2017-12-14
Target enrollment:
Participant gender:
Summary
Evaluation of the following in very young children with Down syndrome: - the efficacy of systematic treatment with L-thyroxine at controlled doses (clinically and by ultrasensitive thyreostimulating hormone (TSH) assay), - the efficacy of systematic folinic acid treatment at a dose of 1 mg/kg/o.i.d, - any interaction between these two treatments.
Phase:
Phase 3
Details
Lead Sponsor:
Institut Jerome Lejeune
Collaborators:
AnticipSante
Ascopharm Groupe Novasco
BIOMNIS
Central Hospital, Nancy, France
Effi-stat
Hôpital Cochin
Inserm U954 (Nancy)
LC2
University of Paris 5 - Rene Descartes
Treatments:
Folic Acid
Hormones
Leucovorin
Levoleucovorin